The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

--

Today's change-- --
 Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

--

Today's change-- --
 Delayed by at least 15 minutes.

Key company metrics

  • Open--
  • Previous close--
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change--
  • Volume--
  • Average volume (10-day)--
  • Average volume (1-month)--
  • Average volume (3-month)--
  • 52-week range-- to --
  • Beta--
  • Trailing P/E--
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
 Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue142171149137
Total other revenue--------
Total revenue142171149137
Gross profit9411710186
Total cost of revenue48554852
Total operating expense183177167157
Selling / general / administrative86797669
Research & development48444436
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-40-6-19-20
Interest income (expense), net non-operating-1000
Gain (loss) on sale of assets--------
Other--------
Income before tax-40-7-19-20
Income after tax-42-7-19-20
Income tax, total1000
Net income-42-7-19-20
Total adjustments to net income--------
Net income before extra. items-42-7-19-20
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-42-7-19-20
Inc. avail. to common incl. extra. items-42-7-19-20
Diluted net income-42-7-19-20
Dilution adjustment0------
Diluted weighted average shares85858484
Diluted EPS excluding extraordinary itemsvalue per share-0.49-0.09-0.22-0.24
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.49-0.09-0.22-0.24